Projects

4D-PRODRUG develops “smart” bio-based materials made from body-like proteins (ELPs) that respond to stimuli such as temperature or pH. This enables the use of 4D printing to produce drug formulations that release active ingredients in a controlled manner—gently, sustainably, tailored to the patient, and documented based on data.

HYBiRD is developing special “bio-inks” that can be used to print skin and cartilage tissue. The goal: to create new materials that can be processed in a 3D printer and are safe and well-tolerated by the body—as a foundation for future therapies and with fewer animal tests.

LASH is developing biohybrid, sugar-based coatings that prevent valuable peptides and proteins from adhering to the walls of microfluidic systems. The goal: more sensitive analyses using minimal sample material—as the foundation for more robust, personalized cancer diagnostics.

SynHeart develops cultured heart muscle tissue using synthetic, collagen-like materials instead of animal collagen. The goal: more stable, reproducible, and clinically applicable heart tissue—as a foundation for personalized therapies, reliable drug testing, and animal-free alternatives.

QPiezoR is developing an active biomaterial that supports the healing of damaged joint cartilage. Sustainably sourced jellyfish collagen is combined with a piezoelectric material—that is, a substance that generates a tiny electrical voltage when pressure is applied. Within the joint, every movement generates small signals that stimulate cells to form new cartilage tissue—similar to what happens in a natural joint.

ProtecKD is researching a novel sensor material for a portable handheld device that detects and distinguishes chemical warfare agents and hazardous substances directly from the air. Custom-designed biohybrid peptides containing dyes react specifically to dangerous gases—providing emergency responders with a clear, rapid, mobile, and reliable warning on-site.